Stifel Maintains Dentsply Sirona(XRAY.US) With Hold Rating, Maintains Target Price $28
Morgan Stanley Maintains Dentsply Sirona(XRAY.US) With Buy Rating, Maintains Target Price $32
Buy Rating for DENTSPLY SIRONA on Next-Gen Dental Innovations and Strategic Growth Potential
Baird Maintains Dentsply Sirona(XRAY.US) With Hold Rating, Maintains Target Price $31
Leerink Partners Maintains Dentsply Sirona(XRAY.US) With Buy Rating, Announces Target Price $34
Piper Sandler Maintains Dentsply Sirona(XRAY.US) With Hold Rating, Maintains Target Price $32
Evercore Maintains Dentsply Sirona(XRAY.US) With Buy Rating, Raises Target Price to $29
Analysts Offer Insights on Healthcare Companies: DENTSPLY SIRONA (XRAY) and Travere Therapeutics (TVTX)
Piper Sandler Sticks to Its Hold Rating for DENTSPLY SIRONA (XRAY)
Dentsply Sirona Analyst Ratings
Barrington Maintains Dentsply Sirona(XRAY.US) With Buy Rating, Maintains Target Price $36
DENTSPLY SIRONA: Poised for Growth With Strategic Initiatives and Strong FY/26 Targets—A Buy Recommendation
Leerink Partners Maintains Dentsply Sirona(XRAY.US) With Buy Rating
DENTSPLY SIRONA (XRAY) Receives a Buy From Leerink Partners
DENTSPLY SIRONA: A Buy Rating Amid CFO Transition and Robust Growth Targets
Needham Reiterates Buy on Dentsply Sirona, Maintains $34 Price Target
Dentsply Sirona Analyst Ratings
Needham Maintains Dentsply Sirona(XRAY.US) With Buy Rating, Maintains Target Price $34
Buy Rating Affirmed Despite CFO Departure: Confidence in DENTSPLY SIRONA's Strategic Initiatives and Growth Prospects
Analysts' Opinions Are Mixed on These Healthcare Stocks: DENTSPLY SIRONA (XRAY), United Therapeutics (UTHR) and Jazz Pharmaceuticals (JAZZ)
No Data
No Data